Next 10 |
home / stock / ci / ci articles
The recent expansion of Novo Nordisk A/S’s (NYSE:NVO) Wegovy’s (semaglutide) FDA approval has sparked a debate over insu...
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 7.66% on an annualized basis producing an average annual return of 15.5...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Cigna Group (NYSE:CI) has outperformed the market over the past 10 years by 5.38% on an annualized basis producing an average annual return of 15.9...
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 8.08% on an annualized basis producing an average annual return of 15.6...
Cigna Group (NYSE: CI) shares were rising in early trading on Monday after the company reported its fourth-quarter results. The results came amid a...
Cboe Global Markets, Inc. (NYSE: CBOE) reported better-than-expected fourth-quarter earnings on Friday. Cboe Global Markets posted adjusted earnin...
Cigna Corporation (NYSE: CI) reported better-than-expected fourth-quarter results and issued a strong revenue outlook on Friday. Cigna reported fo...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 34.1% to $0.3754 on volume of 55,110,141 shares Gamida Cell Ltd. (GMDA) fell 82.7% to $0.0594 on volume of 50,587,982 shares iBio Inc. (IBIO) rose 111.3% to $2.43 on volume of 40,863,066 shares...
2024-03-19 14:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
The recent expansion of Novo Nordisk A/S’s (NYSE:NVO) Wegovy’s (semaglutide) FDA approval has sparked a debate over insu...